1. Academic Validation
  2. Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5- a]pyrimidine scaffold

Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5- a]pyrimidine scaffold

  • RSC Med Chem. 2022 Sep 8;13(10):1150-1196. doi: 10.1039/d2md00192f.
Mohamed M Hammouda 1 2 Hatem E Gaffer 3 Khaled M Elattar 4
Affiliations

Affiliations

  • 1 Department of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University Al-Kharj 11942 Saudi Arabia.
  • 2 Chemistry Department, Faculty of Science, Mansoura University El-Gomhoria Street Mansoura 35516 Egypt.
  • 3 Dyeing and Printing Department, Textile Research Division, National Research Center Dokki Cairo 12622 Egypt.
  • 4 Unit of Genetic Engineering and Biotechnology, Faculty of Science, Mansoura University El-Gomhoria Street Mansoura 35516 Egypt khaledelattar2@yahoo.com +201010655354.
Abstract

Pyrazolo[1,5-a]pyrimidines are the dominant motif of many drugs; for instance, zaleplon and indiplon are sedative agents and ocinaplon was identified as an anxiolytic agent. The importance of this class of compounds lies in its varied and significant biological activities, and accordingly, considerable methods have been devised to prepare these compounds. Hence, Other derivatives of this class of compounds were prepared by substitution reactions with different nucleophiles exploiting the activity of groups linked to the ring carbon and nitrogen atoms. The methods used vary through the condensation reactions of the aminopyrazoles with 1,2-allenic, enaminonitriles, enaminones, 1,3-diketones, unsaturated nitriles, or unsaturated ketones. Alternatively, these compounds are prepared through the reactions of acyclic reagents, as these methods were recently developed efficiently with high yields. The current review highlighted the recent progress of the therapeutic potential of pyrazolo[1,5-a]pyrimidines as antimicrobial, Anticancer, antianxiety, anti-proliferative, analgesic, and antioxidant agents, Carboxylesterase, translocator protein and PDE10A inhibitors, and selective kinase inhibitors.

Figures